FDA Inspection 1093229 — Vojislav Radosavljevic
The FDA completed an inspection of Vojislav Radosavljevic on May 23, 2019 in Belgrade. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Belgrade (Serbia)
Additional details
Clinical Investigator (CI)